 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Vista Pharmaceuticals Ltd in its meeting held on 13.04.2017 has considered and approved the allotment of balance 2,28,714 equity shares and 44,50,000 convertible warrants to the promoters on preferential basis at an issue price of 24.05 per equity share / warrant.
Shares of VISTA PHARMACEUTICALS LTD. was last trading in BSE at Rs.45.7 as compared to the previous close of Rs. 43.55. The total number of shares traded during the day was 135123 in over 135 trades.
The stock hit an intraday high of Rs. 45.7 and intraday low of 45.7. The net turnover during the day was Rs. 6175121.